Dupilumab Earns FDA Priority Review for Add-On COPD Care Dupilumab Earns FDA Priority Review for Add-On COPD Care

The first new COPD treatment in a decade showed safety and effectiveness in a subset of patients with type 2 inflammation.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine Source Type: news